Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The Predictive and Prognostic Factors in Patients with Gastric Cancer Accompanied by Gastric Outlet Obstruction.Gastroenterology research and practice · 2020
   Article
2. Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection.Journal of Cancer · 2019
   Article
3. The value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis: a retrospective study.PloS one · 2013
   Article

Corrections and comments

• Commented on by
  Low perioperative prealbumin level predicts early recurrence after curative pulmonary resection for non-small cell lung cancer.2013
• Comment on
  Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer.2012

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as